Beryl Capital Management LLC - Jan 2, 2025 Form SCHEDULE 13G Schedule Report for Revance Therapeutics, Inc. (RVNC)

Filing Manager
Beryl Capital Management LLC
Reporting Manager
Beryl Capital Management LLC
Security
Revance Therapeutics, Inc. Common Stock
Symbol
RVNC
Shares outstanding
104M shares
Disclosed Ownership
6.36M shares
Ownership
6.1%
Form type
SCHEDULE 13G
Date filed
1/10/2025, 04:52 PM
Date of event
Jan 2, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Beryl Capital Management LLC 6.1% 6.36M 0 6.36M /s/ Andrew Nelson Chief Operating Officer
Beryl Capital Management LP 6.1% 6.36M 0 6.36M /s/ Andrew Nelson Chief Operating Officer of Beryl Capital Management LLC, General Partner of Beryl Capital Management LP
Beryl Capital Partners II LP 5.3% 5.59M 0 5.59M /s/ Andrew Nelson Chief Operating Officer of Beryl Capital Management LLC, General Partner of Beryl Capital Management LP, General Partner of Beryl Capital Partners II
David A. Witkin 6.1% 6.36M 0 6.36M /s/ David A. Witkin Reporting person